Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma

Human Pathology

Volumn 44, Issue 6, 2013, Pages 1024-1030

  Wang, Huamin ^a   Foo, Wai Chin ^a   Rashid, Asif ^a   Wung, Hua ^a   Katz, Matthew H ^a   Lee, Jeffrey E ^a   Pisters, Peter W ^a   Wolff, Robert A ^a   Abbruzzese, James L ^a   Fleming, Jason B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Pancreatic cancer; Prognosis; PTEN; Survival

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84878114129     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.09.001     Document Type: Article

References (31)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
3. D. Li, K. Xie, R. Wolff, and J.L. Abbruzzese Pancreatic cancer Lancet 363 2004 1049 1057
4. R.J. Geer, and M.F. Brennan Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 1993 68 72
5. T.A. Sohn, C.J. Yeo, and J.L. Cameron Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
6. M.A. Tempero, J.P. Arnoletti, and S. Behrman Pancreatic adenocarcinoma J Natl Compr Canc Netw 8 2010 972 1017
7. C. Almoguera, D. Shibata, K. Forrester, J. Martin, N. Arnheim, and M. Perucho Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
8. R.H. Hruban, M. Goggins, J. Parsons, and S.E. Kern Progression model for pancreatic cancer Clin Cancer Res 6 2000 2969 2972
9. R.H. Hruban, K. Takaori, and D.S. Klimstra An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 2004 977 987
10. C.A. Moskaluk, R.H. Hruban, and S.E. Kern p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140 2143
11. V.T. Smit, A.J. Boot, A.M. Smits, G.J. Fleuren, C.J. Cornelisse, and J.L. Bos KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas Nucleic Acids Res 16 1988 7773 7782
12. T. Asano, Y. Yao, J. Zhu, D. Li, J.L. Abbruzzese, and S.A. Reddy The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells Oncogene 23 2004 8571 8580
13. J. Li, C. Yen, and D. Liaw PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
14. P.A. Steck, M.A. Pershouse, and S.A. Jasser Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362
15. B.Z. Stanger, B. Stiles, and G.Y. Lauwers Pten constrains centroacinar cell expansion and malignant transformation in the pancreas Cancer Cell 8 2005 185 195
16. H. Ying, K.G. Elpek, and A. Vinjamoori Pten is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network Cancer Discov 1 2011 158 169
17. R. Hill, J.H. Calvopina, and C. Kim PTEN loss accelerates KrasG12D-induced pancreatic cancer development Cancer Res 70 2010 7114 7124
18. X. Xu, B. Ehdaie, N. Ohara, T. Yoshino, and C.X. Deng Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice Oncogene 29 2010 674 686
19. K. Okami, L. Wu, and G. Riggins Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors Cancer Res 58 1998 509 511
20. A. Sakurada, A. Suzuki, and M. Sato Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary Jpn J Cancer Res 88 1997 1025 1028
21. C. Feng, R. Yao, F. Huang, X. Liu, and W. Nie High level of PTEN expression is associated with low-grade liver metastasis and satisfactory patient survival in pancreatic cancer Arch Med Res 42 2011 584 588
22. H. Wang, H. Wang, W. Zhang, and G.N. Fuller Tissue microarrays: applications in neuropathology research, diagnosis, and education Brain Pathol 12 2002 95 107
23. A.M. Bellizzi, M. Bloomston, X.P. Zhou, O.H. Iwenofu, and W.L. Frankel The mTOR pathway is frequently activated in pancreatic ductal adenocarcinoma and chronic pancreatitis Appl Immunohistochem Mol Morphol 18 2010 442 447
24. M.P. Ebert, G. Fei, and L. Schandl Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1 Br J Cancer 86 2002 257 262
25. N.A. Pham, J. Schwock, V. Iakovlev, G. Pond, D.W. Hedley, and M.S. Tsao Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis BMC Cancer 8 2008 43
26. Y. Kanamori, J. Kigawa, and H. Itamochi PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy Int J Cancer 100 2002 686 689
27. H. Sawai, A. Yasuda, and N. Ochi Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival BMC Gastroenterol 8 2008 56
28. J.M. Tang, Q.Y. He, R.X. Guo, and X.J. Chang Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis Lung Cancer 51 2006 181 191
29. C.P. Hsu, T.Y. Kao, W.L. Chang, S. Nieh, H.L. Wang, and Y.C. Chung Clinical significance of tumor suppressor PTEN in colorectal carcinoma Eur J Surg Oncol 37 2011 140 147
30. K.S. Jang, Y.S. Song, and S.H. Jang Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma Histopathology 56 2010 229 239
31. D.A. Altomare, S. Tanno, and A. De Rienzo Frequent activation of AKT2 kinase in human pancreatic carcinomas J Cell Biochem 87 2002 470 476